Veltek Associates, Inc. Overview
Veltek Associates is a family-led, privately held US manufacturer of contamination-control products and services for cleanrooms. Its core is sterile disinfectants and sporicides, on which it has built adjacent lines in cleanroom garments, wipers, microbial air samplers, cart transfer systems, cleanroom documentation, RFID tracking, contract packaging, laboratory testing and consulting. The company describes this breadth as a full-circle, single-supplier model and supports it with what it reports as 675+ issued and pending patents worldwide and use at more than 1,000 GMP-regulated sites. Its commercial centre of gravity is pharmaceutical and biotechnology aseptic manufacturing, followed by compounding pharmacy and healthcare. Semiconductor and electronics is a stated but secondary vertical, served mainly through low-particulate wipers, garments, monitoring and tracking systems. Veltek competes with much larger groups such as STERIS and Ecolab, and with specialists such as Contec and Texwipe, on technical depth, patented formats and validation documentation rather than scale.
What the company does. Veltek designs and manufactures products and services that control particulate and microbial contamination in classified environments. The company's own description centres on helping cleanroom teams strengthen contamination control across products, validation, documentation and training. Its current site organizes the offering into eight product categories: cleaning and disinfecting agents; wipers and mops; apparel; carts and transfer equipment; environmental monitoring; RFID solutions; cleaning equipment; and cleanroom documentation. Laboratory testing and consulting sit alongside these as services.
Business model. Veltek is a vertically integrated manufacturer of consumables, with a capital-equipment and software layer on top. Revenue mix is not publicly disclosed, but the portfolio implies four income types.
Recurring consumables: Examples: Disinfectants, sporicides, wipers, garments, face masks, cleanroom paper and labels; Character: Repeat purchase tied to cleaning rotations and gowning frequency
Capital equipment: Examples: SMA air samplers, Core2Print printers, Cart2Core carts, Core2Clean Plus systems, RFID hardware; Character: Project-based, with installed-base pull-through
Software: Examples: SMA ICS Pharma Pro, Core2Scan software; Character: System-linked; licensing terms not publicly disclosed
Services: Examples: Disinfectant efficacy testing, residue validation, consulting, training, contract packaging; Character: Fee-based; also a route into product specification
Value chain position. Veltek sits between chemical, nonwoven and component suppliers and the operators of classified manufacturing space. Its chemistry is formulated, filtered, filled, sterilized and documented for cleanroom use. Distribution runs through direct account managers and large laboratory distributors, including Fisher Scientific and VWR/Avantor.
Customer types and end-markets. The company lists ten industries: pharmaceutical manufacturing, biotechnology and ATMP, healthcare, medical device manufacturing, research and laboratory, compounding pharmacy, automotive, aerospace, electronic semiconductor and cosmetic. One supplier database names Baxter and Catalent among customers; the company does not publish a customer list.
Independent characterization. Veltek is best understood as a life-sciences contamination-control specialist with industrial extensions. Its documentation language, sterility claims, regulatory registrations and trade-show calendar all point to GMP pharma as the core franchise. The semiconductor proposition differs in kind: fabs operating at ISO 1-5 care about particles and ionic or organic residues far more than microbial kill. Veltek's semiconductor page therefore highlights its monitoring, disposable products, and cart, documentation and tracking divisions, and does not feature its Sterile Chemical Manufacturing Division among the capabilities listed. Disinfectant-market exposure and semiconductor exposure overlap less than the Wantstats classification might suggest.
Strategy
Veltek does not publish an annual report or investor material. Its strategy can be read from its website, product launches and patents. The central theme is full-circle contamination control under the tagline "Built to Solve, Not Just Supply."
Single-source integration: Evidence: Seven divisions; "one supplier" positioning; products, validation, documentation and training presented as one system; Assessment: Raises switching costs but demands capability across many categories
Patent-led differentiation: Evidence: 675+ issued and pending patents claimed; continuations on air samplers and wipe kits; Assessment: Protects format innovation more than base chemistry
Lower-burden chemistry: Evidence: SPORE-CURE launch in 2025; STERI-PEROX positioned around VOC concerns; DECON-SPORE 300 trademark application pending; Assessment: Responds to operator odor and material corrosion complaints
Digital compliance: Evidence: SMA ICS Pharma Pro, Core2Scan, 21 CFR Part 11 support; Assessment: Moves the company toward data integrity and recurring software value
Regulatory breadth: Evidence: Compliance references across the US, EU, UK, Canada, Japan, South Korea, China, Australia and Panama; Assessment: Supports multinational accounts and distributor sales
Vertical expansion: Evidence: Automotive, aerospace, electronic semiconductor and cosmetic pages added beside life-sciences verticals; Assessment: Early-stage diversification; little named customer evidence
Quality system upgrades: Evidence: ISO 9001:2015 shown as pending and NSF certification as in progress on the company's April 2026 page; Assessment: Near-term credibility milestones for non-pharma buyers
No medium-term financial targets, guidance, cost programs or transformation budgets have been published. No formal sustainability commitment has been disclosed.
Products & Services
Veltek does not publish a price list. Distributor catalogs give indicative pricing; for example, VWR's US listing shows one ALCOH-WIPE case at USD 694.03. Launch years are given only where disclosed. European catalogs often carry the DEC- brand variants (DEC-AHOL, DEC-QUAT) of products sold as DECON- elsewhere.
Sanitizers, disinfectants and sporicides
| Product | Description and key specifications | Primary use |
|---|---|---|
| DECON-AHOL WFI® Formula | Sterile, low-endotoxin isopropyl alcohol with Water for Injection; 60%, 70% or 91%; aerosol, trigger and bulk formats; protected by US 6,123,900 | Surface decontamination in classified areas |
| DECON-AHOL 99% USP IPA | 99% USP isopropyl alcohol in gallon containers | Large-volume GMP use |
| STER-AHOL® WFI | 70% denatured ethanol formulated with WFI; EPA registered | Sanitizing manufacturing and testing areas |
| DECON-SPORE 200® Plus | Peracetic acid and hydrogen peroxide concentrate; hydrogen peroxide 25.60-29.40%, peroxyacetic acid 5.25-6.40%; EPA Reg. 1677-129-68959; Clostridium difficile spore kill in 3 minutes per company data; one-year expiry on a 2020 data sheet | Sporicide, sterilant and disinfectant for aseptic operations and healthcare |
| SPORE-CURE® | Sporicide launched in 2025; marketed as non-corrosive and low-odor; Canadian listing shows hypochlorous acid 0.013% w/w, DIN 02557150 | Sporicidal rotation with lower material and operator burden |
| STERI-PEROX® | Sterile ready-to-use hydrogen peroxide formulated with USP WFI, in 3% and 6% strengths | VOC-conscious rotation and residue-free cleaning |
| HYPO-CHLOR® | Sterile sodium hypochlorite; 0.52% is EPA registered; earlier materials also list 5.25% and 0.25% | Hard-surface disinfection |
| HYPO-CHLOR® Neutral | Neutralized 0.25% and 0.52% sodium hypochlorite with WFI; EPA Reg. 68959-11 for the 0.25% product (2019) | Hypochlorite efficacy with reduced corrosivity |
| DECON-QUAT® 100 | Phosphate-free quaternary ammonium solution; bactericide, virucide and fungicide in 5% blood serum | Hard non-porous surfaces |
| DECON-QUAT® 200C | Quaternary ammonium solution for hard non-porous surfaces | Cleanroom disinfection |
| DECON-CYCLE® II | Sterile low-pH phenolic germicidal detergent; EPA Reg. 211-64-68959 | Rotational disinfectant |
| DECON-PHENE® Plus | Phenolic germicidal detergent | Rotational disinfectant |
| DECON-HAND® | Ethanol-based gel hand sanitizer manufactured as an OTC drug under 21 CFR 211 | Hand decontamination before gloving |
| Dispensing systems | ASEPTI-CLEANSE no-touch dispensers; foot-operated 316L stainless units; wall-mounted aerosol dispensers | Gowning rooms and cleanrooms |
Cleaners, detergents, lubricants, water and buffers
| Product line | Description | Primary use |
|---|---|---|
| DECON-Clean® | Residue remover in liquid and wipe formats | Removing disinfectant residues from walls, floors and steel |
| DECON-Glass® | Glass and plexiglass cleaner | Isolators, windows and panels |
| STEEL-BRIGHT® | Stainless-steel polish in liquid and wipe formats | Rouge, residue and staining on metal surfaces |
| Process2Clean® 1-6 | CIP range: alkaline, acid, hydroxyacetic, general-purpose and neutral-pH additive chemistries | Product-contact equipment cleaning |
| Cage2Wash® 1-5 and N | Alkaline, enhanced alkaline, acid, quaternary, citric and neutralizer chemistries | Automated washing, including laboratory-animal facilities |
| DECON-QUAT® 200V | Quaternary product listed under automation cleaning detergents | Automated washing systems |
| STERI-OIL® 200 | Sterile mineral oil lubricant | Machinery in aseptic areas |
| STERI-SILICON® | Sterile silicone lubricant | Aseptic equipment and components |
| VAI WFI Quality Water™ | Water from a validated six-effect WFI distillation system; not for parenteral administration | Disinfectant preparation and dilution |
| STERI-WATER® | Sterile USP purified water | Formulation, cleaning and rinsing |
| STERI-BUFFER® | Sterile phosphate buffer solution | Bioburden, microbial limits and antimicrobial effectiveness testing |
Wipers, mops and cleaning equipment
| Product | Description | Primary use |
|---|---|---|
| Process2Wipe® | Pre-saturated 70% IPA and 30% WFI knitted or non-woven polyester wipes; laundered and packed under ISO 4 conditions, filled in ISO 7, terminally sterilized to 10-6 SAL | Filling and packaging machinery, critical surfaces |
| ALCOH-WIPE® / ALCOH-GLOVE® | Individually packaged 70% IPA wipes and glove-format wipers | Controlled, low-volume alcohol use |
| STER-AHOL® Wipe | Individually packaged ethanol wipes | Classified environments |
| STERI-PEROX® Wipe | 6% hydrogen peroxide pre-saturated wipe | Aseptic and non-aseptic wipe-downs |
| HYPO-CHLOR® Wipe | 0.52% sodium hypochlorite pre-saturated wipe | Sensitive locations where spray leaves residues |
| DECON-CLEAN® Wipe | Residue-remover pre-saturated wipe | Post-disinfection residue removal |
| STEEL-BRIGHT® Wipe | Stainless-steel cleaning wipe | Metal surfaces |
| DAS-WIPE 100® | Sterile alcohol-saturated wipe | Applications that need a sterile alcohol solution |
| Thio-Wipe® 2% | Sodium thiosulfate wipe | Neutralizing hypochlorite and related uses |
| WipeDown® dry, HC and HiSorb | Continuous polyester and polycellulose dry wipers | General and critical wiping |
| WipeDown® 1-2-3 | Three-step sterile deactivation, decontamination and disinfection kit | USP <800> hazardous drug surfaces |
| TruClean mops | Cleanroom mops | Floors, walls and ceilings |
| CORE2CLEAN® Plus | Configurable sprayer, wet mop or fogger; US 8702869, US 9339567, EP2092990 | Repeatable application across cleanroom classes |
Apparel, transfer, monitoring and documentation
| Product | Description | Primary use |
|---|---|---|
| Easy2Gown System® | Patented garment fold that minimizes operator contact with exterior surfaces | Aseptic gowning |
| MP disposable garments | Microporous garments, including open-face hoods | Critical gowning |
| SMS disposable garments | Spunbond-meltblown-spunbond polypropylene garments | Breathable barrier gowning |
| USP gowns | Barrier gowns tested against USP <800> requirements | Hazardous drug compounding |
| FaceVector®, PF-2 and PF-4 masks | Cleanroom face masks with varying barrier performance | Operator source control |
| Accessories | Boots, shoe covers, bouffants, sweat-less headbands | Full gowning program |
| H-Y Tumble Drum® | Helmke-Yeich tumble drum tester | Garment particle shedding tests |
| CART2CORE® carts | Can/bottle, micro, tray and utility carts with a detachable design | Moving material across cleanroom boundaries |
| SMA Atriums® | Sterilizable sampling heads, including D-50 and Easy Grip variants | Viable air sampling at the point of use |
| SMA OneTouch® ICS and Command | Integrated control and digital display systems | Multi-location facility monitoring |
| SMA ICS Pharma Pro® | Software platform, introduced in 2023, unifying viable air samples, total particles and related data | Data integrity and trending |
| SMA MicroPortable® samplers | Portable air samplers, including ICS version | Spot monitoring |
| SMA® Compressed Air Sampler | Compressed gas sampling | Utility monitoring |
| Core2Scan® | RFID hardware, software and tags; supports 21 CFR Part 11 compliance | Asset, personnel, inventory and process tracking |
| CleanPrint 10™ | Synthetic, cellulose-free, low-particulate, autoclavable writing substrate | Cleanroom paper |
| CleanDox® | Poly-infused bond paper | Batch records, forms and logbooks |
| Core2Write® | Custom logbooks, tags, forms and labels on CleanPrint 10 | GMP documentation inside classified areas |
| Core2Print® | 316L stainless-steel HEPA-filtered wireless printing system; US publications 20150084488, 20160023491 | Printing in controlled areas |
| ABCD Cleanroom Introduction System® | Quadruple-bag packaging for staged entry into critical zones | Common format across sterile products |
Services
| Service | Scope |
|---|---|
| Laboratory testing | Disinfectant efficacy testing, cleaning and residue validation, pre-validation data packages, AOAC protocols, microbial identification |
| Consulting | Cleaning and disinfection validation, environmental monitoring, media fills, smoke studies, gowning and aseptic technique training |
| Contract packaging | Custom GMP packaging, product sterilization, tubing assemblies, aseptic assembly, private label, cleanup kits |
Financial Narrative
Veltek does not publish an income statement, balance sheet or cash flow statement, and it has no public debt or SEC reporting obligation. Five-year revenue, profit, cash flow, balance sheet and return data are not publicly disclosed. The available figures are modelled estimates from data vendors, not reported results.
The estimates cluster at USD 29-35M, but they should be read with care. The Prospeo figure is mechanically linked to a headcount assumption of about 127. If headcount is the 200+ the company stated in 2022, the same revenue range implies about USD 145,000-175,000 per employee, which looks low for a sterile chemical manufacturer with equipment and software lines. Actual revenue could therefore be higher than these estimates suggest. Scientist.com places the company in a USD 1-10M band, which is inconsistent with the company's scale.
Headcount growth of at least one-third between the two company profiles is the only multi-year operating trend that can be supported from company statements. It suggests the business expanded through the pandemic period and afterward, when cleanroom hygiene and sterile manufacturing demand were strong. The addition of Exton sites to the published location list, alongside Malvern, is consistent with that growth, though the timing is not disclosed. Prospeo records no outside funding, implying growth was funded internally or through undisclosed bank facilities. Leverage, liquidity, margins and capital returns are not publicly disclosed.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Division Overview
| Division | Scope | Representative products or services |
|---|---|---|
Sterile Chemical Manufacturing (SCMD) | Validated cleaners, disinfectants, sporicides and process chemicals; described in a company brochure as occupying most of the Malvern facility | DECON-AHOL, DECON-SPORE, HYPO-CHLOR, STERI-PEROX, SimpleMix |
Environmental Control Monitoring (ECMD) | Viable and non-viable monitoring systems | SMA air samplers, SMA OneTouch, SMA ICS Pharma Pro |
Disposable Products Manufacturing (DPMD) | Sterile and non-sterile garments, masks, wipers and consumables | Easy2Gown, FaceVector, WipeDown |
Contract Packaging and Manufacturing (CPMD) | Custom GMP packaging, sterilization, validation and assembly | Tubing kits, barrier packs, private label, RFID drug tracking customization |
Cart Documentation & Tracking | Patented cart transfer, documentation and RFID tracking | Cart2Core, Core2Write, CleanPrint 10, Core2Print, Core2Scan |
VAI Labs | GMP and GLP testing of disinfectant, cleaner and process performance | Time-contact kill studies, AOAC testing, residue validation, microbial identification |
Aseptic Processing, Inc. | Consulting, training and validation support | Cleaning and disinfection programs, environmental monitoring, media fills, gowning training |
Source Details
| Source | Period shown | Revenue estimate (USD Mn) | Basis |
|---|---|---|---|
RocketReach | 2026 | 29.3 | Modelled vendor estimate |
SourceReady | Undated | 29 | Vendor estimate |
Prospeo | Undated | 34.9 | Modelled at USD 275,000 revenue per employee |
Financial Analysis
| Metric | 2017 | 2022 |
|---|---|---|
Employees (company-stated; 2022 is a lower bound) | 150 | 200 |
Region Overview
| Region | Evidence of presence | Commercial route |
|---|---|---|
United States | All published sites; Fisher Scientific and VWR Americas sales meetings; regional sales territories | Direct account managers and national distributors |
Canada | Health Canada product listing for SPORE-CURE; biocide and natural health product compliance references | Regulated product registrations |
Mexico and Latin America | ExpoFarma attendance in Mexico City; VWR Mexico supplier listing; shipment records showing Mexico and Chile | Distributor-led |
Europe | Avantor catalogs across the UK, Belgium, Switzerland, Poland and Hungary; EU BPR, REACH and MDR references | Distributor-led |
Asia-Pacific | Registrations or frameworks cited for Japan, South Korea, China and Australia; Thermo Fisher ANZ brochures; shipment records showing India and Vietnam | Distributor-led |
Analyst Conclusions
Management guidance and consensus forecasts do not exist in public form. Market forecasts imply mid-single-digit growth in cleanroom disinfectants and about 7-8% in cleanroom consumables and semiconductor cleanroom spending. A portfolio spanning both could reasonably track those rates, but Veltek's own growth is not publicly disclosed.
Bull case:
-
Annex 1 and contamination-control strategies reward an integrated supplier of chemistry, monitoring, documentation and training, and Veltek has built all of these in-house.
-
SPORE-CURE and a possible DECON-SPORE 300 refresh the sporicide range just as customers seek lower odor and corrosion.
-
SMA ICS Pharma Pro and Core2Scan could expand recurring revenue while adding data lock-in across a reported 1,000+ sites.
Bear case:
-
Ecolab and STERIS can bundle disinfectants with service and global supply, and Ecolab now competes on the same low-odor claim.
-
FDA observations in 2018 and 2025 show that quality-system gaps can recur, and any escalation would damage a brand built on compliance.
-
Reliance on one Pennsylvania cluster, a single technical figurehead and limited transparency constrain global accounts and raise succession risk.
Key catalysts and monitorables (next 12 months):
ISO 9001:2015 and NSF outcomes: What to watch: Completion of the pending and in-progress items on the compliance page
FDA follow-up: What to watch: Any new inspection result for FEI 3001342291
Sporicide pipeline: What to watch: DECON-SPORE 300 trademark progress and new EPA or BPR approvals
Klercide response: What to watch: Customer switching in sporicide rotations
Semiconductor traction: What to watch: Named wins, SEMICON participation or ISO 1-3 product launches
Ownership or succession: What to watch: Any leadership transition, minority sale or strategic transaction
Site development: What to watch: Disclosure of Exton functions or new capacity
Trade-secret case: What to watch: Reported disposition of the Chester County action
Analyst verdict. Veltek Associates is a technically credible specialist whose influence in sterile contamination control exceeds what its size would suggest. Few companies of its scale combine sterile chemistry, viable air sampling, gowning systems, cleanroom documentation, RFID tracking, testing and consulting under one roof. Its founder-family leadership has turned this breadth into a coherent proposition, and its CEO's long record with PDA, USP and regulators gives it a voice in the very standards its customers must meet. Forty-five years of format-level invention, from sterile alcohol aerosols to SimpleMix and Easy2Gown, are the company's most durable competitive evidence.
The limitations are equally clear. Veltek remains a Pennsylvania-based supplier, with no published financial record and little evidence of scale outside life sciences. Its semiconductor position, which prompted its inclusion in this ecosystem, is real but secondary. Fabs buy on particles, residues and supply reliability, where Contec, Texwipe, Berkshire and DuPont are stronger incumbents and Veltek's sterile validation advantage matters less. The most relevant semiconductor opportunities are selective: monitoring, RFID tracking, cleanroom documentation, and specialist wipers and garments, rather than disinfectants.
The most important near-term tests are commercial and regulatory. SPORE-CURE must establish itself against Ecolab's new entrant, and the quality-system credentials shown as pending need to be completed. FDA's 2018 and 2025 observations were not escalated, but a company selling compliance must keep its own record clean. Overall, Veltek should be viewed as a well-positioned, defensible niche franchise and a credible strategic asset, with its true financial quality unknown. Any commercial or investment decision should begin with direct diligence on revenue, margin, customer concentration, registration ownership and succession.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Role | Background |
|---|---|---|
Arthur L. Vellutato, Jr. | President and CEO; President and Senior Consultant, Aseptic Processing, Inc. | Over 30 years of experience, including VP Quality Assurance, VP Validation and VP Manufacturing roles at the company; 75+ industry publications; PDA and USP faculty |
Doug Paradis | Technology leader | Listed as CTO by Crunchbase, ZoomInfo and CB Insights; The Org's chart now shows him as Consultant; previously CTO at Anexinet |
Karen Corliss | General Counsel | Listed by The Org |
Jeff Churchvara | VP Facilities | Named inventor on multiple air-sampling patents |
Matthew Smith | Senior Director of Sales | Listed by The Org |
Heather Greaves | Marketing Director | Listed by The Org |
Gary Soliwoda | Director, Quality Assurance | Listed by The Org |
Kevin McMurtrie | Global Business Manager, documentation, transfer and RFID | With the company since 2016; previously held roles at CCH, a Wolters Kluwer business, from 1995 to 2015 |
Lee Jackowsky | Assistant Controller | Listed by The Org; with the company since January 2022 |
Competitive Landscape
Key Competitors
| Competitor | Competes in | Relative position |
|---|---|---|
STERIS plc | Disinfectants, sterility assurance, aseptic services | Far larger, global; strongest direct life-sciences rival |
Ecolab Inc. | Klercide disinfectants, pharma hygiene | Scale, service network and Global High-Tech exposure to fabs |
Contec, Inc. | Wipes, mops, disinfectants | Closest private peer; strong in microelectronics and life sciences |
Texwipe (ITW) | Wipers, swabs, cleanroom chemicals | Strong semiconductor and life-sciences wiper brand |
DuPont | Cleanroom apparel | Dominant in Tyvek garments |
Kimberly-Clark | Gloves, apparel, wipers | Broad hygiene scale |
Berkshire Corporation | Wipers and cleanroom consumables | Semiconductor and pharma wiper specialist |
Valutek | Apparel and wipes | Mid-size contamination-control supplier |
Micronova Manufacturing | Cleanroom mops and cleaning tools | Specialist in application tools |
Decon Labs | Ethanol and related chemicals | Alcohol competitor; named by ZoomInfo |
Thermo Fisher Scientific | Cleanroom disinfectants and consumables | Competitor and channel partner |
Whiteley, Tristel | Sterile surface disinfectants | International disinfectant challengers |
Merck KGaA, bioMérieux, Sartorius, Climet, Lighthouse, TSI | Air sampling and monitoring | Compete with the SMA line |
Metric | Veltek Associates | STERIS plc (FY Mar 2026) |
Revenue (USD Mn) | 29-35, third-party estimates | 5,935.9 |
Most relevant unit revenue (USD Mn) | — | 588.8 (Life Sciences) |
Revenue growth | — | 8.7% |
Net margin | — | 13.2% (continuing operations) |
Ownership | Private | NYSE: STE |
“—” = not publicly disclosed.
Recent Developments
The company issues few formal press releases. The table combines company events, IP and regulatory records. Competitor events are marked.
